Analyst Ratings for Xenon Pharmaceuticals (XENE)
XENE Rating Summary
XENE Price Target Summary
- Highest: $66.00 (Stifel)
- Lowest: $49.00 (Wells Fargo)
- Average: $57.71
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$57.71 (+37.6%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$57.71 (+37.6%)
* Over Last 12-Mos
Rating Score: 10 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/24/2026 | Wolfe Research | Rudy Li | New Coverage | Outperform (N/A) |
60.00 (N/A) |
42.23 (41.94) |
-0.69% | Details |
| 9/3/2025 | Wells Fargo » Updated 2/27/2026 |
Benjamin Burnett | New Coverage | Overweight (N/A) |
49.00 (48.00) |
38.71 (41.94) |
8.34% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


